Search

everythinglearnresearchcommunity

for

Search:↓

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Certain foods and supplements can help treat skin diseases alongside medication.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Ongoing research and innovation are crucial for improving skin care and treatment.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Scoring systems help doctors assess and treat skin diseases effectively.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

Technology, like mobile apps and AI, is improving skin condition diagnosis and treatment.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Inclusive dermatology aims to provide personalized skin care for all by addressing diverse needs and disparities.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.

The DLQI is a key tool for measuring quality of life in dermatology.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

New understanding and treatments for hair loss are improving, but more research is needed.

Alopecia areata is linked to more chronic illnesses, a specific lamp helps with notalgia paresthetica itch, pycnogenol aids melasma treatment, and dupilumab improves severe atopic dermatitis in children.